about
Pharmaceutical and toxicological properties of engineered nanomaterials for drug deliveryA machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.govPediatric Pathology In The Year 2050.Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.Molecular farming, patents and access to medicines.Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects.Nanoparticles: small and mighty.Magnetoliposomes and their potential in the intelligent drug-delivery field.Economic and societal dimensions of nanotechnology-enabled drug delivery.A prospective overview of the essential requirements in molecular modeling for nanomedicine design.Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.The impact of effective patents on future innovations in nanomedicine.Are high drug loading nanoparticles the next step forward for chemotherapy?Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Adding to the mix: integrating ELSI into a National Nanoscale Science and Technology Center.Nanostructured SBA-15 host applied in ketorolac tromethamine release system.Obtaining of Sol-Gel Ketorolac-Silica Nanoparticles: Characterization and Drug Release Kinetics
P2860
Q28396383-D7AA7B73-FDBB-441D-AA31-880EEF774184Q28396566-C11122D9-875B-4B52-940C-961FD27B491BQ33444490-6C1E7C43-5B6C-4814-BEF3-2FBB5309D25AQ36394925-FCD81E24-258E-4856-93BA-34D76F1CEDDFQ37776712-24D7496E-9595-4764-A332-A0EF2105CBFEQ37805491-ECE1E848-CB07-4A11-A88D-5BAB2080324AQ37805494-331EB90F-AA52-44F4-ABE5-2E452BDD5022Q37845900-5F616E95-AA4B-42FA-AA1F-919BD1A04E09Q38074445-CBB4086E-C3B1-4C64-90E0-E472ADB5B39DQ38081220-4EF365BF-33CC-4167-B7C7-FDEEAC7FB10AQ38107498-2C0C1B19-3C7D-4A36-896B-CA5E21EC43A1Q38587494-1564AFBC-F075-4061-ADEF-EF37C83F5BD9Q39060269-A59319E5-2029-423B-8401-185704EDA56DQ39540783-17602F80-EF21-426D-8007-C3523DDB774CQ39649136-3028AB22-40D4-4AA7-AEE7-D3058DE13EC2Q42636559-DB37947E-9BD7-4B7D-AC76-9BF4619DC21DQ47962563-980BC284-FAA3-4D51-BFFA-47FB11EF1911Q48550642-F6AFC529-B37D-4D75-BCE5-3F1CE9ADC21DQ50580226-BB3B878E-F9E6-4FB1-9725-5B7E7600A16EQ59018346-6FF33FED-5CD2-4696-8A46-2E62E158A70C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Patents and nanomedicine.
@en
type
label
Patents and nanomedicine.
@en
prefLabel
Patents and nanomedicine.
@en
P2860
P356
P1433
P1476
Patents and nanomedicine
@en
P2093
P2860
P304
P356
10.2217/17435889.2.3.351
P50
P577
2007-06-01T00:00:00Z